Testing effectiveness (Phase 2)Study completedNCT02251717
What this trial is testing
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection
Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 114